Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies

Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy and other methods cannot capture all of the features of tumour genomes. A new diagnostic concept called "liquid biopsy" has received...

Full description

Saved in:
Bibliographic Details
Published inOncoTargets and therapy Vol. 14; pp. 3417 - 3428
Main Authors Meng, Yiming, Sun, Jing, Zheng, Yang, Zhang, Guirong, Yu, Tao, Piao, Haozhe
Format Journal Article
LanguageEnglish
Published Macclesfield Dove Medical Press Limited 01.01.2021
Taylor & Francis Ltd
Dove
Subjects
Biomarkers
Biopsy
Blood platelets
Bone marrow
Cancer
Cancer therapies
Cytoplasm
Development and progression
Diagnosis
Diagnostic equipment (Medical)
Drug resistance
Exosomes
External stimuli
Gastric cancer
Genomes
Genomics
Health aspects
Hematology
Hematopoietic stem cells
Inflammation
Liver cancer
Lung cancer
Medical prognosis
Megakaryocytes
Metastases
Metastasis
Microenvironments
mRNA
Peripheral blood
Physiological aspects
Physiology
Platelets
Review
RNA
Stem cells
Survival analysis
Thyroid gland
Tumor microenvironment
Tumors
China
Online AccessGet full text

Cover

Abstract Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy and other methods cannot capture all of the features of tumour genomes. A new diagnostic concept called "liquid biopsy" has received widespread attention in recent years. Liquid biopsy has changed the clinical practice of oncology and is widely used to guide targeted drug utilization, monitor disease progression and track drug resistance. The latest research subject in liquid biopsy is platelets. Platelets originate from multifunctional haematopoietic stem cells in the bone marrow haematopoietic system. They are small cells from the cytoplasm of bone marrow megakaryocytes. Their main physiological functions are to participate in the processes of physiological haemostasis and coagulation. Tumour cells transfer biomolecules (such as RNA) to platelets through direct contact and release of exosomes, which changes the platelet precursor RNA. Under the stimulation of tumour cells and the tumour microenvironment, platelet precursor mRNA is spliced into mature RNA and converted into functional protein to respond to external stimuli, forming tumour-educated platelets (TEPs). The detection of TEPs in the peripheral blood of patients is expected to be used in clinical tumour diagnosis. This emerging liquid biopsy method can replace and supplement the current tumour detection methods. Further research on the role of platelets in tumour diagnosis will help provide a novel theoretical basis for clinical tumour diagnosis. Keywords: liquid biopsy, platelet, diagnosis, RNA, noninvasive
AbstractList Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy and other methods cannot capture all of the features of tumour genomes. A new diagnostic concept called "liquid biopsy" has received widespread attention in recent years. Liquid biopsy has changed the clinical practice of oncology and is widely used to guide targeted drug utilization, monitor disease progression and track drug resistance. The latest research subject in liquid biopsy is platelets. Platelets originate from multifunctional haematopoietic stem cells in the bone marrow haematopoietic system. They are small cells from the cytoplasm of bone marrow megakaryocytes. Their main physiological functions are to participate in the processes of physiological haemostasis and coagulation. Tumour cells transfer biomolecules (such as RNA) to platelets through direct contact and release of exosomes, which changes the platelet precursor RNA. Under the stimulation of tumour cells and the tumour microenvironment, platelet precursor mRNA is spliced into mature RNA and converted into functional protein to respond to external stimuli, forming tumour-educated platelets (TEPs). The detection of TEPs in the peripheral blood of patients is expected to be used in clinical tumour diagnosis. This emerging liquid biopsy method can replace and supplement the current tumour detection methods. Further research on the role of platelets in tumour diagnosis will help provide a novel theoretical basis for clinical tumour diagnosis. Keywords: liquid biopsy, platelet, diagnosis, RNA, noninvasive
Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy and other methods cannot capture all of the features of tumour genomes. A new diagnostic concept called "liquid biopsy" has received widespread attention in recent years. Liquid biopsy has changed the clinical practice of oncology and is widely used to guide targeted drug utilization, monitor disease progression and track drug resistance. The latest research subject in liquid biopsy is platelets. Platelets originate from multifunctional haematopoietic stem cells in the bone marrow haematopoietic system. They are small cells from the cytoplasm of bone marrow megakaryocytes. Their main physiological functions are to participate in the processes of physiological haemostasis and coagulation. Tumour cells transfer biomolecules (such as RNA) to platelets through direct contact and release of exosomes, which changes the platelet precursor RNA. Under the stimulation of tumour cells and the tumour microenvironment, platelet precursor mRNA is spliced into mature RNA and converted into functional protein to respond to external stimuli, forming tumour-educated platelets (TEPs). The detection of TEPs in the peripheral blood of patients is expected to be used in clinical tumour diagnosis. This emerging liquid biopsy method can replace and supplement the current tumour detection methods. Further research on the role of platelets in tumour diagnosis will help provide a novel theoretical basis for clinical tumour diagnosis.Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy and other methods cannot capture all of the features of tumour genomes. A new diagnostic concept called "liquid biopsy" has received widespread attention in recent years. Liquid biopsy has changed the clinical practice of oncology and is widely used to guide targeted drug utilization, monitor disease progression and track drug resistance. The latest research subject in liquid biopsy is platelets. Platelets originate from multifunctional haematopoietic stem cells in the bone marrow haematopoietic system. They are small cells from the cytoplasm of bone marrow megakaryocytes. Their main physiological functions are to participate in the processes of physiological haemostasis and coagulation. Tumour cells transfer biomolecules (such as RNA) to platelets through direct contact and release of exosomes, which changes the platelet precursor RNA. Under the stimulation of tumour cells and the tumour microenvironment, platelet precursor mRNA is spliced into mature RNA and converted into functional protein to respond to external stimuli, forming tumour-educated platelets (TEPs). The detection of TEPs in the peripheral blood of patients is expected to be used in clinical tumour diagnosis. This emerging liquid biopsy method can replace and supplement the current tumour detection methods. Further research on the role of platelets in tumour diagnosis will help provide a novel theoretical basis for clinical tumour diagnosis.
Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy and other methods cannot capture all of the features of tumour genomes. A new diagnostic concept called "liquid biopsy" has received widespread attention in recent years. Liquid biopsy has changed the clinical practice of oncology and is widely used to guide targeted drug utilization, monitor disease progression and track drug resistance. The latest research subject in liquid biopsy is platelets. Platelets originate from multifunctional haematopoietic stem cells in the bone marrow haematopoietic system. They are small cells from the cytoplasm of bone marrow megakaryocytes. Their main physiological functions are to participate in the processes of physiological haemostasis and coagulation. Tumour cells transfer biomolecules (such as RNA) to platelets through direct contact and release of exosomes, which changes the platelet precursor RNA. Under the stimulation of tumour cells and the tumour microenvironment, platelet precursor mRNA is spliced into mature RNA and converted into functional protein to respond to external stimuli, forming tumour-educated platelets (TEPs). The detection of TEPs in the peripheral blood of patients is expected to be used in clinical tumour diagnosis. This emerging liquid biopsy method can replace and supplement the current tumour detection methods. Further research on the role of platelets in tumour diagnosis will help provide a novel theoretical basis for clinical tumour diagnosis.
Audience Academic
Author Piao, Haozhe
Sun, Jing
Zhang, Guirong
Zheng, Yang
Meng, Yiming
Yu, Tao
Author_xml – sequence: 1
  givenname: Yiming
  surname: Meng
  fullname: Meng, Yiming
– sequence: 2
  givenname: Jing
  surname: Sun
  fullname: Sun, Jing
– sequence: 3
  givenname: Yang
  surname: Zheng
  fullname: Zheng, Yang
– sequence: 4
  givenname: Guirong
  surname: Zhang
  fullname: Zhang, Guirong
– sequence: 5
  givenname: Tao
  orcidid: 0000-0002-1171-2789
  surname: Yu
  fullname: Yu, Tao
– sequence: 6
  givenname: Haozhe
  surname: Piao
  fullname: Piao, Haozhe
BookMark eNptkl1rHCEUhqWkNB_tVf-AUCiFsFudcdTpRSHdph-wkEK2dwVxneOswdWNzhTy7-OQLc2GcC4Ufd73oO85RUchBkDoLSXzijLx8Wq1ml_XlLZEvEAnlAo5421Njh7tj9FpzjeEcC4r9god14yItpLiBP355fUAHob8Ca82gC-3kHoXerzwLjijPf7qdB9iHpzJWIduopLe3eHrojKDiwFHixc6GEh46W5H1-EvLu6yg_wavbTaZ3izX8_Q72-Xq8WP2fLq-8_FxXJmmGTDzDSGAHBiJetIs2YUDG9kS2RL65pWUHPaCluRxnaNMbJpacW4pZ20Yi05E_UZ-vzguxvXW-gMhCFpr3bJbXW6U1E7dXgT3Eb18a-SlDMpeDH4sDdI8XaEPKitywa81wHimFXV1Fy0kjdtQd89QW_imEJ5XqEYlVyUUP5TvfagXLCx9DWTqbrgoi4lm6pQ82eoUh1snSkpW1fODwTvHwk2oP2wydGPUwz5EKQPoEkx5wRWGTfoCSsdnFeUqGl2VJkdtZ-dojl_ovn3gc_R9zxqwow
CitedBy_id crossref_primary_10_1007_s12094_022_02937_1
crossref_primary_10_1016_j_semcancer_2022_01_006
crossref_primary_10_3389_fmolb_2024_1385238
crossref_primary_10_4103_jcrt_jcrt_1212_22
crossref_primary_10_1007_s12032_023_02128_0
crossref_primary_10_3389_fmed_2021_788869
crossref_primary_10_3389_fonc_2023_1272788
crossref_primary_10_1007_s13402_023_00815_8
crossref_primary_10_3390_cancers14174136
Cites_doi 10.1182/bloodadvances.2020003410
10.1136/gutjnl-2019-320282
10.1016/j.biomaterials.2020.120141
10.1038/s41598-018-24539-0
10.3389/fimmu.2019.01373
10.4149/neo_2017_118
10.1155/2019/9213074
10.1186/s12885-018-5252-2
10.7150/ijbs.36284
10.1007/s13277-015-4774-3
10.5582/bst.2020.03230
10.1038/s41591-019-0379-5
10.2147/CMAR.S164227
10.1186/s13048-018-0382-3
10.1016/j.ctrv.2020.102106
10.1111/crj.12605
10.1016/j.jss.2019.04.052
10.7534/j.issn.1009-2137.2017.03.035
10.1097/MD.0000000000012504
10.1053/j.gastro.2019.03.070
10.1016/j.hbpd.2019.04.009
10.18632/oncotarget.11551
10.1002/jso.24166
10.1038/s41392-020-0119-9
10.2217/fon-2018-0591
10.1371/journal.pone.0177137
10.1007/s00432-019-03032-9
10.1634/theoncologist.2019-0057
10.1186/s12885-019-5504-9
10.22034/APJCP.2018.19.3.699
10.3390/ijms19010100
10.22037/uj.v0i0.4735
10.1039/C8TB02301H
10.1111/jth.13720
10.1002/hon.2467
10.1016/j.biomaterials.2019.119699
10.1159/000500230
10.1002/cam4.3087
10.7717/peerj.4139
10.3390/cells8111382
10.1155/2019/6036979
10.1182/blood-2017-03-743211
10.5125/jkaoms.2017.43.5.305
10.1016/j.xcrm.2020.100101
10.1186/s12885-018-5022-1
10.1161/CIRCRESAHA.117.310795
10.3389/fonc.2020.595613
10.2147/CMAR.S195654
10.1016/j.cca.2019.03.1634
10.3390/cancers12092666
10.3233/JAD-180181
10.1186/s12876-020-01225-y
10.1016/j.ccell.2015.09.018
10.1002/14651858.CD001884.pub3
10.1016/j.ccell.2020.03.012
10.1016/j.canlet.2016.04.038
10.12659/MSM.911125
10.1159/000495337
10.3233/CBM-170975
10.1186/s12864-020-07147-z
10.1007/s10555-017-9674-0
10.1155/2019/9438750
10.1038/s41598-017-11053-y
10.3233/CBM-181231
10.18632/aging.102366
10.1016/j.tmrv.2020.09.008
10.1097/MNM.0000000000000452
10.1038/s41598-017-07168-x
10.1186/s12967-019-1950-z
10.1093/dote/dox125
10.1186/s12885-020-07650-2
10.1111/1759-7714.13823
10.5606/ehc.2021.76357
10.2147/CMAR.S273328
10.1007/s12282-015-0635-6
10.1159/000489833
10.3389/fimmu.2020.608849
10.1016/j.smim.2016.10.008
10.3389/fimmu.2020.01962
10.1007/s13277-016-5090-2
10.1186/s13048-020-00682-z
10.1007/s00277-016-2819-3
10.1038/s41598-019-40589-4
10.1016/j.clinre.2020.03.023
10.3390/ijms21020623
10.2147/CMAR.S257727
10.3892/ol.2016.4913
10.1007/s11255-020-02379-0
10.12659/MSM.914426
10.3390/cancers12061372
10.2147/CMAR.S193949
10.1182/blood.2019001388
10.1038/nrc.2017.51
10.1016/j.cca.2016.11.008
10.3390/ijms21249585
10.3390/jcm9082513
10.20471/acc.2019.58.03.03
10.1002/hon.2321
10.1016/j.anl.2016.06.009
10.1080/10245332.2017.1365458
ContentType Journal Article
Copyright COPYRIGHT 2021 Dove Medical Press Limited
2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 Meng et al.
2021 Meng et al. 2021 Meng et al.
Copyright_xml – notice: COPYRIGHT 2021 Dove Medical Press Limited
– notice: 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 Meng et al.
– notice: 2021 Meng et al. 2021 Meng et al.
DBID AAYXX
CITATION
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
LK8
M0S
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.2147/OTT.S311907
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
ProQuest Research Library
Biological Science Database
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Meng et al
EISSN 1178-6930
EndPage 3428
ExternalDocumentID PMC8164876
A673737852
10_2147_OTT_S311907
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0YH
29N
2WC
53G
5VS
7X7
8FE
8FH
8FI
8FJ
8G5
AAYXX
ABDBF
ABUWG
ACGFO
ACUHS
ADBBV
ADRAZ
AENEX
AFKRA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
ESX
F5P
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
LK8
M2O
M48
M7P
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TDBHL
TR2
TUS
UKHRP
VDV
PMFND
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c484t-c5c0ee60f84d05b41ec658908913312e36197f205fd5cc8591246f1d8f7b86473
IEDL.DBID M48
ISSN 1178-6930
IngestDate Thu Aug 21 18:18:30 EDT 2025
Fri Jul 11 05:23:23 EDT 2025
Fri Jul 25 11:49:59 EDT 2025
Tue Jun 17 21:29:54 EDT 2025
Tue Jun 10 20:36:14 EDT 2025
Thu May 22 20:50:19 EDT 2025
Tue Jul 01 02:09:35 EDT 2025
Thu Apr 24 23:05:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c484t-c5c0ee60f84d05b41ec658908913312e36197f205fd5cc8591246f1d8f7b86473
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-1171-2789
OpenAccessLink https://www.proquest.com/docview/2541867214?pq-origsite=%requestingapplication%
PMID 34079287
PQID 2541867214
PQPubID 3933336
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8164876
proquest_miscellaneous_2536798659
proquest_journals_2541867214
gale_infotracmisc_A673737852
gale_infotracacademiconefile_A673737852
gale_healthsolutions_A673737852
crossref_citationtrail_10_2147_OTT_S311907
crossref_primary_10_2147_OTT_S311907
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Macclesfield
PublicationPlace_xml – name: Macclesfield
PublicationTitle OncoTargets and therapy
PublicationYear 2021
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove
References Gu (ref66) 2016; 23
Sakin (ref58) 2019; 9
Shi (ref85) 2018; 24
Suzuki-Inoue (ref76) 2019; 134
Xing (ref91) 2019; 15
Kelly (ref78) 2020; 34
Simurda (ref10) 2018; 19
Cho (ref104) 2021; 5
Fu (ref72) 2018; 19
Maurer (ref106) 2020; 11
Liu (ref38) 2020; 12
Sakin (ref48) 2020; 25
Yun (ref64) 2017; 7
Ma (ref6) 2020; 255
Väyrynen (ref19) 2019; 17
Zhang (ref57) 2016; 37
Yin (ref51) 2020; 20
Xu (ref25) 2020; 20
Watrowski (ref31) 2016; 37
Wang (ref14) 2018; 97
Brand (ref2) 2019; 24
Wang (ref83) 2019; 495
Midorikawa (ref20) 2020; 14
Shen (ref71) 2016; 12
Best (ref89) 2017; 15
Korniluk (ref40) 2019; 2019
Luo (ref103) 2016; 377
Corbeau (ref81) 2020; 12
Fernandez-Rozadilla (ref1) 2021; 10
Chang (ref47) 2019; 19
Tomimaru (ref21) 2016; 113
Li (ref45) 2019; 2019
Cirillo (ref87) 2020; 91
Liu (ref99) 2019; 145
Zhang (ref37) 2017; 5
Li (ref46) 2017; 7
Gou (ref54) 2019; 11
Tanriverdi (ref68) 2016; 21
Ohuchi (ref23) 2017; 64
Goswami (ref100) 2020; 21
Dong (ref92) 2020
Elmoamly (ref84) 2018; 23
Shen (ref55) 2018; 22
Marin Oyarzún (ref11) 2019; 10
Sun (ref56) 2018; 31
Rupa-Matysek (ref61) 2017; 35
Wang (ref16) 2019; 15
Sol (ref98) 2020; 1
O’Leary (ref13) 2019; 157
Życzkowski (ref65) 2020; 52
Demir (ref75) 2016; 37
Iannacone (ref12) 2016; 28
Cui (ref67) 2018; 21
Scheiner (ref22) 2019; 8
Sökmen (ref69) 2021; 32
Zhang (ref53) 2019; 18
Akingbade (ref42) 2018; 63
Omar (ref59) 2018; 12
Gao (ref62) 2017; 25
Oh (ref17) 2019; 242
Ochi (ref35) 2017; 96
Gutiontov (ref15) 2020; 9
Zhang (ref52) 2014; 19
Sol (ref88) 2017; 36
Zhang (ref36) 2020; 143
Stojkovic Lalosevic (ref28) 2019; 2019
Amanda (ref80) 2019
Yin (ref50) 2018; 8
Takeuchi (ref82) 2017; 12
Mai (ref7) 2020; 232
Koupenova (ref77) 2018; 122
Hu (ref33) 2020; 13
Desborough (ref44) 2017; 7
Chen (ref29) 2016; 36
Malehmir (ref9) 2019; 25
Garrido-Navas (ref107) 2019; 8
Kilgour (ref3) 2020; 37
De Palma (ref102) 2017; 17
Pardo (ref26) 2017; 44
Choi (ref39) 2019; 141
Asghar (ref97) 2020; 44
Sheng (ref73) 2019; 25
Zheng (ref18) 2017; 473
Li (ref5) 2020; 11
Barale (ref43) 2020; 21
Qin (ref74) 2018; 11
von Felden (ref4) 2020; 69
Sit (ref49) 2019; 58
Wu (ref27) 2019; 19
Zhou (ref60) 2018; 36
Li (ref105) 2018; 6
Shimodaira (ref34) 2020; 17
Liu (ref90) 2019; 145
Heinhuis (ref95) 2020; 12
Luo (ref93) 2018; 10
Yang (ref94) 2019; 11
Wang (ref101) 2019; 11
Best (ref96) 2015; 28
Park (ref70) 2017; 43
Belluco (ref30) 2018; 18
Gutiérrez-Herrero (ref8) 2020; 5
Qu (ref24) 2020; 12
Yilmaz (ref32) 2017; 38
Hisada (ref79) 2017; 130
Crafa (ref41) 2020; 9
Dovizio (ref86) 2020; 21
Zhuang (ref63) 2016; 7
References_xml – volume: 25
  start-page: 227
  year: 2020
  ident: ref48
  publication-title: J BUON
– volume: 5
  start-page: 1947
  year: 2021
  ident: ref104
  publication-title: Blood Adv
  doi: 10.1182/bloodadvances.2020003410
– volume: 69
  start-page: 2025
  year: 2020
  ident: ref4
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-320282
– volume: 255
  start-page: 120141
  year: 2020
  ident: ref6
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.120141
– volume: 8
  start-page: 6014
  year: 2018
  ident: ref50
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-24539-0
– volume: 10
  start-page: 1373
  year: 2019
  ident: ref11
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01373
– volume: 19
  start-page: 351
  year: 2014
  ident: ref52
  publication-title: Asian Pac J Cancer Prev
– volume: 64
  start-page: 140
  year: 2017
  ident: ref23
  publication-title: Neoplasma
  doi: 10.4149/neo_2017_118
– volume: 2019
  start-page: 9213074
  year: 2019
  ident: ref40
  publication-title: Mediators Inflamm
  doi: 10.1155/2019/9213074
– volume: 19
  start-page: 15
  year: 2019
  ident: ref47
  publication-title: BMC Cancer
  doi: 10.1186/s12885-018-5252-2
– volume: 15
  start-page: 1977
  year: 2019
  ident: ref91
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.36284
– volume: 37
  start-page: 9323
  year: 2016
  ident: ref57
  publication-title: Tumour Biol
  doi: 10.1007/s13277-015-4774-3
– volume: 14
  start-page: 368
  year: 2020
  ident: ref20
  publication-title: Biosci Trends
  doi: 10.5582/bst.2020.03230
– volume: 25
  start-page: 641
  year: 2019
  ident: ref9
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0379-5
– volume: 10
  start-page: 1449
  year: 2018
  ident: ref93
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S164227
– volume: 11
  start-page: 10
  year: 2018
  ident: ref74
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-018-0382-3
– volume: 91
  start-page: 102106
  year: 2020
  ident: ref87
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2020.102106
– volume: 12
  start-page: 922
  year: 2018
  ident: ref59
  publication-title: Clin Respir J
  doi: 10.1111/crj.12605
– volume: 242
  start-page: 296
  year: 2019
  ident: ref17
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2019.04.052
– volume: 25
  start-page: 827
  year: 2017
  ident: ref62
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
  doi: 10.7534/j.issn.1009-2137.2017.03.035
– volume: 21
  start-page: 840
  year: 2016
  ident: ref68
  publication-title: J BUON
– volume: 97
  start-page: e12504
  year: 2018
  ident: ref14
  publication-title: Medicine
  doi: 10.1097/MD.0000000000012504
– volume: 157
  start-page: 34
  year: 2019
  ident: ref13
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.03.070
– volume: 18
  start-page: 223
  year: 2019
  ident: ref53
  publication-title: Hepatobiliary Pancreat Dis Int
  doi: 10.1016/j.hbpd.2019.04.009
– volume: 7
  start-page: 62640
  year: 2016
  ident: ref63
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11551
– volume: 113
  start-page: 565
  year: 2016
  ident: ref21
  publication-title: J Surg Oncol
  doi: 10.1002/jso.24166
– volume: 5
  start-page: 29
  year: 2020
  ident: ref8
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-0119-9
– volume: 15
  start-page: 827
  year: 2019
  ident: ref16
  publication-title: Future Oncol
  doi: 10.2217/fon-2018-0591
– volume: 12
  start-page: e0177137
  year: 2017
  ident: ref82
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0177137
– volume: 145
  start-page: 2713
  year: 2019
  ident: ref99
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-019-03032-9
– volume: 24
  start-page: e1371
  year: 2019
  ident: ref2
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2019-0057
– volume: 19
  start-page: 314
  year: 2019
  ident: ref27
  publication-title: BMC Cancer
  doi: 10.1186/s12885-019-5504-9
– volume: 19
  start-page: 699
  year: 2018
  ident: ref72
  publication-title: Asian Pac J Cancer Prev
  doi: 10.22034/APJCP.2018.19.3.699
– volume: 19
  start-page: 100
  year: 2018
  ident: ref10
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms19010100
– volume: 17
  start-page: 42
  year: 2020
  ident: ref34
  publication-title: Urol J
  doi: 10.22037/uj.v0i0.4735
– volume: 6
  start-page: 7354
  year: 2018
  ident: ref105
  publication-title: J Mater Chem B
  doi: 10.1039/C8TB02301H
– volume: 15
  start-page: 1295
  year: 2017
  ident: ref89
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.13720
– volume: 36
  start-page: 104
  year: 2018
  ident: ref60
  publication-title: Hematol Oncol
  doi: 10.1002/hon.2467
– volume: 232
  start-page: 119699
  year: 2020
  ident: ref7
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2019.119699
– volume: 143
  start-page: 9
  year: 2020
  ident: ref36
  publication-title: Acta Haematol
  doi: 10.1159/000500230
– volume: 9
  start-page: 4667
  year: 2020
  ident: ref15
  publication-title: Cancer Med
  doi: 10.1002/cam4.3087
– volume: 5
  start-page: e4139
  year: 2017
  ident: ref37
  publication-title: PeerJ
  doi: 10.7717/peerj.4139
– volume: 8
  start-page: 1382
  year: 2019
  ident: ref107
  publication-title: Cells
  doi: 10.3390/cells8111382
– volume: 2019
  start-page: 6036979
  year: 2019
  ident: ref28
  publication-title: Dis Markers
  doi: 10.1155/2019/6036979
– volume: 130
  start-page: 1499
  year: 2017
  ident: ref79
  publication-title: Blood
  doi: 10.1182/blood-2017-03-743211
– volume: 43
  start-page: 305
  year: 2017
  ident: ref70
  publication-title: J Korean Assoc Oral Maxillofac Surg
  doi: 10.5125/jkaoms.2017.43.5.305
– volume: 1
  start-page: 100101
  year: 2020
  ident: ref98
  publication-title: Cell Rep Med
  doi: 10.1016/j.xcrm.2020.100101
– volume: 18
  start-page: 1094
  year: 2018
  ident: ref30
  publication-title: BMC Cancer
  doi: 10.1186/s12885-018-5022-1
– volume: 122
  start-page: 337
  year: 2018
  ident: ref77
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.117.310795
– volume: 10
  start-page: 595613
  year: 2021
  ident: ref1
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.595613
– volume: 11
  start-page: 3351
  year: 2019
  ident: ref101
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S195654
– volume: 495
  start-page: 191
  year: 2019
  ident: ref83
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2019.03.1634
– volume: 12
  start-page: 2666
  year: 2020
  ident: ref81
  publication-title: Cancers
  doi: 10.3390/cancers12092666
– volume: 63
  start-page: 1235
  year: 2018
  ident: ref42
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-180181
– volume: 20
  start-page: 143
  year: 2020
  ident: ref51
  publication-title: BMC Gastroenterol
  doi: 10.1186/s12876-020-01225-y
– volume: 28
  start-page: 666
  year: 2015
  ident: ref96
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.09.018
– volume: 7
  start-page: CD001884
  year: 2017
  ident: ref44
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD001884.pub3
– volume: 37
  start-page: 485
  year: 2020
  ident: ref3
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.03.012
– volume: 377
  start-page: 174
  year: 2016
  ident: ref103
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2016.04.038
– volume: 24
  start-page: 8655
  year: 2018
  ident: ref85
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.911125
– volume: 141
  start-page: 176
  year: 2019
  ident: ref39
  publication-title: Acta Haematol
  doi: 10.1159/000495337
– volume: 21
  start-page: 909
  year: 2018
  ident: ref67
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-170975
– volume: 145
  start-page: 2713
  year: 2019
  ident: ref90
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-019-03032-9
– volume: 21
  start-page: 744
  year: 2020
  ident: ref100
  publication-title: BMC Genomics
  doi: 10.1186/s12864-020-07147-z
– volume: 36
  start-page: 263
  year: 2017
  ident: ref88
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-017-9674-0
– volume: 2019
  start-page: 9438750
  year: 2019
  ident: ref45
  publication-title: Biomed Res Int
  doi: 10.1155/2019/9438750
– volume: 7
  start-page: 10261
  year: 2017
  ident: ref46
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-11053-y
– volume: 22
  start-page: 559
  year: 2018
  ident: ref55
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-181231
– volume: 11
  start-page: 8998
  year: 2019
  ident: ref94
  publication-title: Aging
  doi: 10.18632/aging.102366
– volume: 34
  start-page: 286
  year: 2020
  ident: ref78
  publication-title: Transfus Med Rev
  doi: 10.1016/j.tmrv.2020.09.008
– volume: 37
  start-page: 393
  year: 2016
  ident: ref75
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0000000000000452
– volume: 7
  start-page: 6700
  year: 2017
  ident: ref64
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-07168-x
– volume: 17
  start-page: 199
  year: 2019
  ident: ref19
  publication-title: J Transl Med
  doi: 10.1186/s12967-019-1950-z
– volume: 31
  start-page: 31
  year: 2018
  ident: ref56
  publication-title: Dis Esophagus
  doi: 10.1093/dote/dox125
– volume: 36
  start-page: 482
  year: 2016
  ident: ref29
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
– volume: 20
  start-page: 1152
  year: 2020
  ident: ref25
  publication-title: BMC Cancer
  doi: 10.1186/s12885-020-07650-2
– year: 2020
  ident: ref92
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.13823
– year: 2019
  ident: ref80
  publication-title: Haematologica
– volume: 32
  start-page: 198
  year: 2021
  ident: ref69
  publication-title: Jt Dis Relat Surg
  doi: 10.5606/ehc.2021.76357
– volume: 12
  start-page: 9765
  year: 2020
  ident: ref24
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S273328
– volume: 23
  start-page: 752
  year: 2016
  ident: ref66
  publication-title: Breast Cancer
  doi: 10.1007/s12282-015-0635-6
– volume: 8
  start-page: 203
  year: 2019
  ident: ref22
  publication-title: Liver Cancer
  doi: 10.1159/000489833
– volume: 11
  start-page: 608849
  year: 2020
  ident: ref106
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.608849
– volume: 28
  start-page: 555
  year: 2016
  ident: ref12
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2016.10.008
– volume: 11
  start-page: 1962
  year: 2020
  ident: ref5
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.01962
– volume: 37
  start-page: 12079
  year: 2016
  ident: ref31
  publication-title: Tumour Biol
  doi: 10.1007/s13277-016-5090-2
– volume: 13
  start-page: 78
  year: 2020
  ident: ref33
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-020-00682-z
– volume: 96
  start-page: 1
  year: 2017
  ident: ref35
  publication-title: Ann Hematol
  doi: 10.1007/s00277-016-2819-3
– volume: 9
  start-page: 3959
  year: 2019
  ident: ref58
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-40589-4
– volume: 44
  start-page: 836
  year: 2020
  ident: ref97
  publication-title: Clin Res Hepatol Gastroenterol
  doi: 10.1016/j.clinre.2020.03.023
– volume: 21
  start-page: 623
  year: 2020
  ident: ref43
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21020623
– volume: 12
  start-page: 6069
  year: 2020
  ident: ref38
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S257727
– volume: 12
  start-page: 2501
  year: 2016
  ident: ref71
  publication-title: Oncol Lett
  doi: 10.3892/ol.2016.4913
– volume: 52
  start-page: 885
  year: 2020
  ident: ref65
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-020-02379-0
– volume: 25
  start-page: 4527
  year: 2019
  ident: ref73
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.914426
– volume: 12
  start-page: 1372
  year: 2020
  ident: ref95
  publication-title: Cancers
  doi: 10.3390/cancers12061372
– volume: 11
  start-page: 1615
  year: 2019
  ident: ref54
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S193949
– volume: 38
  start-page: 346
  year: 2017
  ident: ref32
  publication-title: Eur J Gynaecol Oncol
– volume: 134
  start-page: 1912
  year: 2019
  ident: ref76
  publication-title: Blood
  doi: 10.1182/blood.2019001388
– volume: 17
  start-page: 457
  year: 2017
  ident: ref102
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2017.51
– volume: 473
  start-page: 198
  year: 2017
  ident: ref18
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2016.11.008
– volume: 21
  start-page: 9585
  year: 2020
  ident: ref86
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21249585
– volume: 9
  start-page: 2513
  year: 2020
  ident: ref41
  publication-title: J Clin Med
  doi: 10.3390/jcm9082513
– volume: 58
  start-page: 417
  year: 2019
  ident: ref49
  publication-title: Acta Clin Croat
  doi: 10.20471/acc.2019.58.03.03
– volume: 35
  start-page: 456
  year: 2017
  ident: ref61
  publication-title: Hematol Oncol
  doi: 10.1002/hon.2321
– volume: 44
  start-page: 313
  year: 2017
  ident: ref26
  publication-title: Auris Nasus Larynx
  doi: 10.1016/j.anl.2016.06.009
– volume: 23
  start-page: 89
  year: 2018
  ident: ref84
  publication-title: Hematology
  doi: 10.1080/10245332.2017.1365458
SSID ssj0066824
Score 2.2770784
SecondaryResourceType review_article
Snippet Due to the inherent molecular heterogeneity of metastatic tumours and the dynamic evolution ability of tumour genomes, tumour tissues obtained through biopsy...
SourceID pubmedcentral
proquest
gale
crossref
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 3417
SubjectTerms Biomarkers
Biopsy
Blood platelets
Bone marrow
Cancer
Cancer therapies
Cytoplasm
Development and progression
Diagnosis
Diagnostic equipment (Medical)
Drug resistance
Exosomes
External stimuli
Gastric cancer
Genomes
Genomics
Health aspects
Hematology
Hematopoietic stem cells
Inflammation
Liver cancer
Lung cancer
Medical prognosis
Megakaryocytes
Metastases
Metastasis
Microenvironments
mRNA
Peripheral blood
Physiological aspects
Physiology
Platelets
Review
RNA
Stem cells
Survival analysis
Thyroid gland
Tumor microenvironment
Tumors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0gvgifmK06goFQYhNsrMf54vUaimiItTCPQgh2ezSgyO59u7-f2eSvdgU8SUvO2GTmf367c7-fgAHufRYGZenNkifotOzdGYUPaqAQeOsqeo-QfaHPj3Hr3M1jxtu65hWuRsT-4G66RzvkR8SkGHutSLHj6vLlFWj-HQ1SmjchjtMXcYpXWY-Ai6tbYHDnTxW4zkkjPz-TJIha8dem4VujsU38yOvTTgnD-B-XCmKoyG0D-GWbx_B3e_xLPwx_P65pHUiuX39QVCwBW8vseKQiFSfS_F5SKNjImZRtQ1bMYOAOOu1byggogvimMN-Jb4tLreLRnxadKs1gecncH7y5dfxaRq1ElKHFjepUy7zXmfBYpOpGnPvaG3Bh3oEQvPCSwJKJhSZCo1yjknrCtQhb2wwtdVo5FPYa7vWPwOB6GulfKZd7VE1WDEmklpVNpdVnZsE3u18V7pIJM56FsuSAAU7uiRHl9HRCRyMxquBP-PfZq85COVw-XPsdeURy-hIY1WRwNvegvsd1eaqeH2AvpkZrCaW-xNL6i9uWrwLdBn767r827oSeDMW85ucg9b6bss2ko-stJolYCYNZPwz5uqelrSLi56z2xIspYnn-f8rfwH3Cs6Z6bd49mFvc7X1L2nRs6lf9S37D93VAeI
  priority: 102
  providerName: ProQuest
Title Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies
URI https://www.proquest.com/docview/2541867214
https://www.proquest.com/docview/2536798659
https://pubmed.ncbi.nlm.nih.gov/PMC8164876
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ta9RAEB76AuIX8RWj9VyhIAip2ezrCSJtbTnElmI9OEEIyWYXD45cey-g_96ZJBfM0Q9-yZed3OVmZm_2yc4-D8AhF17mxvHYBuFj6fQwHhqFlzzIoOWwzIu6QfZSj8byy0RNdmAjxtk6cHkntCM9qfFidvT79s8nnPAfqY2ZS_Mese_RteBY2swu7GNJMjRDL2S3naC1bdRtOUIm0v5rDupt39wrTdt_0NtNk_9UofOH8KBdPrLjJt6PYMdXj-HeRbtB_gR-Xs1w8YixWH5gmAGM3jmRDBFr-T9n7HPTW0fszCyvSrIiWgF2XQviYJTYPLBTyoUF-zq9XU9LdjKd3ywRUT-F8fnZ99NR3AooxE5auYqdcon3OglWlokqJPcOFxy004fIlKdeIHoyIU1UKJVzxGSXSh14aYMprJZGPIO9al7558Ck9IVSPtGu8FKVMiegJLTKLRd5wU0E7za-y1zLLk4iF7MMUQY5OkNHZ62jIzjsjG8aUo27zV5TELLmRGg3FbNj0tYRxqo0gre1BaUHfpvL2zMF-MxEa9WzPOhZ4iRy_eFNoLNNDmaInYnuDx8rgjfdMN1JjWmVn6_JRtA-llbDCEwvQbpfRgTe_ZFq-qsm8raIVbEavfiPT38J91Pqpqlf_hzA3mqx9q9wObQqBrCb_Bjh1UzMAPZPzi6vvg3q9P8LqTILWQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3ra9RAEB_qFdQv4hPTVrtCRRBik-wrJ4j0ydVej2Jb6IdCTDa7eHAk194d4j_l3-hMHqcp4rd-yZedvGZnZ_a3O_sbgK2QW5FqE_qx49YXRvX9vpZ4SZ1wSvTzNKsSZEdqcCG-XMrLFfjVnoWhtMrWJ1aOOi8NrZFvI5Ah7rUoFJ-n1z5VjaLd1baERm0Wx_bnD4Rss09H-9i_b6Po8OB8b-A3VQV8I2Ix9400gbUqcLHIA5mJ0BqMwrT9hXAtjCxHSKFdFEiXS2OI3i0SyoV57HQWK6E5PvcerAqOUKYHq7sHo9Ovre9XKo5EfQqQ6v9sIyr_cMZDDLq6E_due__bGZl_hbjDx_ComZuyndqYnsCKLZ7C_ZNm9_0ZXJ1OcGaKHT37yNC8GC1oUY0j1pCLTth-nbhH1M8sLXKSIs4CdlZV20ETYKVje2RoN2w4vl6Mc7Y7LqczhOvP4eJO9PgCekVZ2JfAhLCZlDZQJrNC5iIlFMaVTOOQp1moPXjf6i4xDXU5VdCYJAhhSNEJKjppFO3B1lJ4WjN2_FtskzohqY-bLsd5skOFe7iOZeTBu0qCRjq-zaTNgQX8ZuLM6khudCRxhJpuc9vRSeMhZskfe_bgzbKZ7qSst8KWC5LhtEmmZN8D3TGQ5Z8RO3i3pRh_r1jCYwTCGOrW_v_yTXgwOD8ZJsOj0fE6PIwoY6daYNqA3vxmYV_hlGuevW7snMG3ux5avwHQJj47
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB9qheKL-InRaleoCEK8bPYrJ4jUnkdraynUwj0IabLZxYMjufbuEP81_zpnklw0RXzrS1528jU7s7O_3dnfAOxy4WRmLA8TL1worR6GQ6PwknnptRwWWV4nyJ7og3P5eaImG_BrfRaG0irXY2I9UBeVpTXyAQIZ4l6LuRz4Ni3idDT-ML8MqYIU7bSuy2k0JnLkfv5A-LZ4fzjCvn4Vx-NPX_cPwrbCQGhlIpehVTZyTkc-kUWkcsmdxYhMW2EI3XjsBMIL4-NI-UJZS1RvsdSeF4k3eaKlEfjcW3DbCMXJx8ykA3taJ7FszgNSJaAB4vO3Z4Jj-DW9CHg9DlzPzfwr2I3vwd12lsr2GrO6DxuufABbX9p9-Ifw7XSGc1Ts8sU7hobGaGmLqh2xlmZ0xkZNCh-RQLOsLEiK2AvYWV13B42BVZ7tk8ldsePp5WpasI_Tar5A4P4Izm9Ei49hs6xK9wSYlC5XykXa5k6qQmaEx4RWWcJFlnMTwJu17lLbkphTLY1ZimCGFJ2iotNW0QHsdsLzhrvj32I71Alpc_C08_h0j0r4CJOoOIDXtQT5PL7NZu3RBfxmYs_qSW73JNFXbb953dFpO1Ys0j-WHcDLrpnupPy30lUrkhG0XabVMADTM5Duz4gnvN9STr_XfOEJQmIMek____Id2EKHSo8PT46ewZ2YUnfqlaZt2FxerdxznHst8xe1kTO4uGmv-g0h2UEL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelets%3A+The+Emerging+Clinical+Diagnostics+and+Therapy+Selection+of+Cancer+Liquid+Biopsies&rft.jtitle=OncoTargets+and+therapy&rft.au=Meng%2C+Yiming&rft.au=Sun%2C+Jing&rft.au=Zheng%2C+Yang&rft.au=Zhang%2C+Guirong&rft.date=2021-01-01&rft.issn=1178-6930&rft.eissn=1178-6930&rft.volume=14&rft.spage=3417&rft_id=info:doi/10.2147%2FOTT.S311907&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-6930&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-6930&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-6930&client=summon